On September 12, 2023, the Centers for Disease Control and Prevention (CDC) released updated COVID-19 vaccine recommendations, advising everyone older than 6 months of age to update their vaccinations. Updated COVID-19 vaccines were created to target the currently circulating strains of COVID-19 and they significantly reduce the risk of developing severe complications.
Who is eligible for the updated COVID-19 vaccine?
Recommendations for use of the 2023-2024 formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine:
- Everyone ages 5 years and older is recommended to receive 1 does of updated mRNA COVID-19 vaccine.
- Children ages 6 months - 4 years
- Initial vaccination: should receive either 2 doses of updated (2023-2024 Formula) Moderna or 3 doses of updated (2023-2024 Formula) Pfizer-BioNTech COVID-19 vaccines.
- Received previous mRNA doses: need 1 or 2 doses of updated (2023-2024 Formula) Moderna or updated (2023-2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses.
- People who are moderately or severely immunocompromised
- Initial vaccination: should receive a 3-dose series of updated (2023-2024 Formula) Moderna or updated (2023-2024 Formula) Pfizer-BioNTech COVID-19 vaccine.
- Received previous mRNA dosses: need 1 or 2 doses of updated (2023-2024 Formula) Moderna or updated (2023-2024 Formula) Pfizer-BioNTech COVID-19 vaccine, depending on the number of prior doses.
- May receive 1 or more additional updated (2023-2024) Formula mRNA COVID-19 vaccine doses
- Bivalent mRNA COVID-19 vaccines are no longer recommended in the United States
- Studies conducted throughout the COVID-19 pandemic demonstrate that it is safe to receive both a COVID-19 vaccine and a flu vaccine at the same visit.
CDC has long recommended that everyone stay up to date with COVID-19 vaccination. You are up to date if you have received the updated vaccine recommended for you by CDC.
COVID-19 vaccines are effective. The COVID-19 vaccines continue to reduce the risk of severe disease, hospitalization, and death, including against the most common variants circulating now. COVID-19 vaccines have undergone and continue to undergo the most intense safety monitoring in U.S. history.
For more information about who is eligible for the updated COVID-19 vaccine, click here.
What is the Bridge Access Program?
On September 14, 2023, the CDC officially launched the Bridge Access Program, a unique program that will help maintain uninsured and underinsured individuals' access to COVID-19 care at their local pharmacies, through existing public health infrastructure, and at their local health centers.
The Bridge Access Program will provide continued free coverage for the estimate 25-30 million adults who would have otherwise lost access to affordable COVID-19 vaccines. This program is available through December 31, 2024. If you have questions regarding the program, click here for the frequently asked questions.
COVID-19 Resources
These resources are designed to help you decrease vaccine hesitancy and increase vaccination rates in your community.
This project was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000580). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.
LATEST NEWS
19 November 2024
The FAIR Project works directly with maternal and child home-visiting programs to provide comprehensive...
23 October 2023
In February 2021, the National Nurse-Led Care Consortium (NNCC) partnered with this Centers for Disease...
STAY CONNECTED TO NURSE-LED CARE
